Question 1

What are the potential side effects of using pimecrolimus cream with topical corticosteroids?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis clinical trial (NCT00121381). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options we have tried?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis clinical trial (NCT00121381). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like for my child?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis clinical trial (NCT00121381). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific precautions we should take while using this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis clinical trial (NCT00121381). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will we need to be involved in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis clinical trial (NCT00121381). Contact the study team or your healthcare provider for specific answers.

Question 6

What should we do if my child's condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis clinical trial (NCT00121381). Contact the study team or your healthcare provider for specific answers.

What this study is about